Sensitive diagnostics are essential tools for curbing the spread of infectious diseases. To rapidly detect the presence of a pathogen or biomarker in a patient sample, scientists incorporate lateral flow immunoassays into diagnostic tests such as COVID rapid tests.
Download this tech note from Cytiva to discover
- How lateral flow immunoassays work
- Conjugated Polymer Nanoparticles (CPNs™), a new class of bioimaging probes that increase an immunoassay’s sensitivity
- How to combine CPNs with ImageQuant™ 800 for optimal signal detection
